Therapeutic Asset Ratings

208 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Amikacin Solid Tumors	Hospital Universitari Vall d'Hebron Research Institute	P4	B (56)
Cefepime Solid Tumors	Hospital Universitari Vall d'Hebron Research Institute	P4	B (56)
Levofloxacin Iv Solid Tumors	Hospital Universitari Vall d'Hebron Research Institute	P4	B (56)
METRONIDAZOLE Solid Tumors	Hospital Universitari Vall d'Hebron Research Institute	P4	B (56)
TEIKOPLANIN Solid Tumors	Hospital Universitari Vall d'Hebron Research Institute	P4	B (56)
ERIBULIN MONOMETHANESULFONATE Solid Tumors	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	P3	B (56)
Incb161734 Solid Tumors	Incyte Corporation	P3	B (56)
VOLITINIB Solid Tumors	AstraZeneca	P3	B (56)
METHOTREXATE Solid Tumors	Yancheng First People's Hospital	P2	B (56)
Obinutuzumab Solid Tumors	M.D. Anderson Cancer Center	P2	B (56)
Romiplostim Solid Tumors	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P2	B (56)
Avelumab Solid Tumors	Pfizer	P3	CCC (55)
DARATUMUMAB Solid Tumors	Hellenic Society of Hematology	P1/2	CCC (55)
ceftazidime Solid Tumors	Hospital Universitari Vall d'Hebron Research Institute	P4	CCC (54)
Ciprofloxacin Solid Tumors	Hospital Universitari Vall d'Hebron Research Institute	P4	CCC (54)
Lapatinib Solid Tumors	Deraya University	P2	CCC (54)
Mesna Solid Tumors	M.D. Anderson Cancer Center	P2	CCC (54)
Meropenem Solid Tumors	Hospital Universitari Vall d'Hebron Research Institute	P4	CCC (53)
Cmp 001 Solid Tumors	Pfizer	P3	CCC (52)
Favezelimab Solid Tumors	Merck Sharp & Dohme LLC	P3	CCC (52)
human hyaluronidase isozyme-5 (HYAL5, sperm adhesion molecule 1, SPAM1, hyaluronidase PH-20, EC:3.2.1.35) fragment (3-433, 1-431 in the current sequence) engineered variant with the structural domain replaced by the corresponding region of human hyaluronidase isozyme-1 (HYAL1)(<sup>306</sup>TLSIMRSMKSCLLDDNYMETI<sup>326</sup>><sup>304</sup>SWENTRTKESCQAIKEYMDTT<sup>324</sup>), produced in Chinese hamster ovary (CHO) cells, cell line DG44, glycoform alfa Solid Tumors	Merck Sharp & Dohme LLC	P3	CCC (52)
Ivuxolimab Solid Tumors	Pfizer	P3	CCC (52)
Lorlatanib Solid Tumors	Pfizer	P3	CCC (52)
ANTI-PD-L1 MONOCLONAL ANTIBODY KN035 Solid Tumors	3D Medicines (Sichuan) Co., Ltd.	P2	CCC (52)
RIFALDAZINE Solid Tumors	Boehringer Ingelheim	P1	CCC (52)

Showing 26 to 50 of 208 assets

PreviousPage 2 of 9Next